Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI)

Q: What does CUSIP 48576U106 represent in this 13F holders report?

CUSIP 48576U106 is the security identifier for KPTI - Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held KPTI - Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share in Q2 2018?

108 institutional investors reported KPTI - Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share for Q2 2018. Use the holders table for investor-level position and value details.

CUSIP: 48576U106

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 22,242,217
Total 13F shares: 43,354,403
Share change: +12,592,281
Total reported value: $736,589,579
Put/Call ratio: 109%
Price per share: $16.99
Number of holders: 108
Value change: +$217,013,290
Number of buys: 74
Number of sells: 30

Quarterly Holders Quick Answers

What is CUSIP 48576U106?
CUSIP 48576U106 identifies KPTI - Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2018
Previous quarter: Q1 2018

Recent filing periods for CUSIP 48576U106:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of KPTI - Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	31%	6,808,383	$91,369,000	—	31 Mar 2018	13F
Palo Alto Investors LP	13F	Company	17%	3,679,978	$49,385,000	—	31 Mar 2018	13F
FMR LLC	13F	Company	14%	3,032,392	$40,695,000	—	31 Mar 2018	13F
BlackRock Finance, Inc.	13F	Company	12%	2,758,063	$37,014,000	—	31 Mar 2018	13F
FRANKLIN RESOURCES INC	13F	Company	9.2%	2,051,984	$27,538,000	—	31 Mar 2018	13F
Point72 Asset Management, L.P.	13F	Company	8.8%	1,958,527	$26,283,000	—	31 Mar 2018	13F
VANGUARD GROUP INC	13F	Company	8.7%	1,936,043	$25,981,000	—	31 Mar 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	5.7%	1,272,268	$17,074,000	—	31 Mar 2018	13F
STATE STREET CORP	13F	Company	4.4%	988,931	$13,272,000	—	31 Mar 2018	13F
Avoro Capital Advisors LLC	13F	Company	2.5%	560,658	$7,524,000	—	31 Mar 2018	13F
TEACHERS ADVISORS, LLC	13F	Company	2%	434,437	$5,830,000	—	31 Mar 2018	13F
NORTHERN TRUST CORP	13F	Company	1.8%	397,294	$5,331,000	—	31 Mar 2018	13F
Schonfeld Strategic Advisors LLC	13F	Company	1.6%	362,892	$4,870,000	—	31 Mar 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.4%	321,323	$4,312,000	—	31 Mar 2018	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.4%	313,356	$4,205,000	—	31 Mar 2018	13F
JPMORGAN CHASE & CO	13F	Company	1.3%	289,367	$3,883,000	—	31 Mar 2018	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	1.2%	262,388	$3,521,000	—	31 Mar 2018	13F
DOHENY ASSET MANAGEMENT /CA	13F	Company	1%	228,990	$3,073,000	—	31 Mar 2018	13F
S.c.a. Candriam	13F	Individual	0.99%	220,000	$2,953,000	—	31 Mar 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.85%	189,485	$2,541,000	—	31 Mar 2018	13F
D. E. Shaw & Co., Inc.	13F	Company	0.79%	175,541	$2,356,000	—	31 Mar 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.76%	168,188	$2,258,000	—	31 Mar 2018	13F
Bank of New York Mellon Corp	13F	Company	0.75%	167,106	$2,243,000	—	31 Mar 2018	13F
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC	13F	Company	0.7%	155,525	$2,087,000	—	31 Mar 2018	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.67%	150,022	$2,013,000	—	31 Mar 2018	13F
MORGAN STANLEY	13F	Company	0.66%	147,612	$1,981,000	—	31 Mar 2018	13F
Iguana Healthcare Management, LLC	13F	Company	0.56%	125,000	$1,678,000	—	31 Mar 2018	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.55%	121,888	$1,636,000	—	31 Mar 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.5%	111,545	$1,497,000	—	31 Mar 2018	13F
CITADEL ADVISORS LLC	13F	Company	0.42%	93,940	$1,261,000	—	31 Mar 2018	13F
KENNEDY CAPITAL MANAGEMENT LLC	13F	Company	0.42%	92,720	$1,244,000	—	31 Mar 2018	13F
UNITED SERVICES AUTOMOBILE ASSOCIATION	13F	Company	0.39%	86,376	$1,159,000	—	31 Mar 2018	13F
VIRTUS ADVISERS, LLC	13F	Company	0.37%	81,325	$1,091,000	—	31 Mar 2018	13F
Ghost Tree Capital, LLC	13F	Company	0.35%	76,786	$1,030,000	—	31 Mar 2018	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.33%	72,630	$975,000	—	31 Mar 2018	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.31%	68,736	$923,000	—	31 Mar 2018	13F
Swiss National Bank	13F	Company	0.29%	64,150	$861,000	—	31 Mar 2018	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.24%	54,111	$726,000	—	31 Mar 2018	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.23%	52,000	$698,000	—	31 Mar 2018	13F
Opus Point Partners Management, LLC	13F	Company	0.22%	50,000	$671,000	—	31 Mar 2018	13F
CREDIT SUISSE AG/	13F	Company	0.21%	46,078	$619,000	—	31 Mar 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.2%	44,892	$602,000	—	31 Mar 2018	13F
TCW GROUP INC	13F	Company	0.2%	43,448	$583,000	—	31 Mar 2018	13F
BARCLAYS PLC	13F	Company	0.19%	42,985	$577,000	—	31 Mar 2018	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.17%	37,700	$506,000	—	31 Mar 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.16%	36,036	$483,000	—	31 Mar 2018	13F
RHUMBLINE ADVISERS	13F	Company	0.15%	33,560	$450,000	—	31 Mar 2018	13F
Trexquant Investment LP	13F	Company	0.14%	31,017	$416,000	—	31 Mar 2018	13F
ProShare Advisors LLC	13F	Company	0.12%	27,442	$368,000	—	31 Mar 2018	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.12%	26,000	$349,000	—	31 Mar 2018	13F

Institutional Holders of Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) as of Q2 2018

As of 30 Jun 2018, Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) was held by 108 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,354,403 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, Consonance Capital Management LP, Palo Alto Investors LP, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, FRANKLIN RESOURCES INC, FMR LLC, Point72 Asset Management, L.P., and MILLENNIUM MANAGEMENT LLC. This page lists 108 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

Q2 2018 holders

108

Holder diff

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 Value $	Q2 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.